Probiotic-Prebiotic Combo Shows Promise for Aging Immune Systems

This completed clinical trial examined whether synbiotic supplementation could combat immunosenescence, the natural decline in immune function that occurs with aging. Researchers at the University of Roehampton investigated how combining probiotics with prebiotics might restore immune strength in elderly populations who face increased vulnerability to infections and reduced vaccine responses.

The randomized controlled study enrolled 40 healthy elderly participants over 13 months, testing three different interventions: LGG probiotic with Promitor prebiotic fiber, Promitor alone, and LGG-PB12 probiotic with Promitor. This synbiotic approach aimed to simultaneously introduce beneficial bacteria while providing the nutrients needed for their survival and growth.

The research addressed a critical health challenge, as aging significantly reduces levels of beneficial gut bacteria that support immune function. Previous studies suggested that Lactobacilli and Bifidobacteria strains could enhance immune responses through cytokine modulation, but few randomized placebo-controlled trials had definitively proven these effects in elderly populations.

While specific results weren't detailed in available summaries, this study contributes valuable data on safe, non-invasive interventions for age-related immune decline. The synbiotic strategy represents a promising approach because prebiotics create optimal conditions for probiotic survival, potentially amplifying benefits beyond either supplement alone.

For longevity-focused individuals, this research highlights the potential of targeted gut microbiome interventions to maintain immune resilience with aging. Understanding how specific probiotic-prebiotic combinations affect immune markers could inform personalized strategies for healthy aging and disease prevention in older adults.